Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Strategy for Critical Lesions of Coronary Artery Disease

NCT03195621 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.

NCT NCT03195621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03195621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Strategy for Critical Lesions of Coronary Artery Disease
Lead sponsor
Southeast University, China
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2016
Completion date
June 30, 2019
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, coronary artery disease progression